Literature DB >> 27619357

18F-FDG PET/CT in gastric MALT lymphoma: a bicentric experience.

Domenico Albano1,2, Mattia Bertoli3,4, Paola Ferro4, Federico Fallanca5, Luigi Gianolli5, Maria Picchio5, Raffaele Giubbini6, Francesco Bertagna6.   

Abstract

PURPOSE: The role of 18F-FDG-PET/CT in evaluating gastric MALT lymphoma is still controversial. In the literature the detection rate of 18F-FDG-PET/CT in patients with gastric MALT lymphoma is variable, and the reason for this heterogeneity is not still clear. Our aim was to investigate the particular metabolic behavior of these lymphoma.
MATERIALS AND METHODS: Sixty-nine patients (26 female, 43 male) with histologically confirmed gastric MALT lymphoma who underwent a 18F-FDG-PET/CT for initial staging from two centers were included. The PET images were analyzed visually and semi-quantitatively by measuring the maximum standardized uptake value (SUVmax), lesion-to-liver SUVmax ratio, and lesion-to-blood pool SUVmax ratio and compared with Ann Arbor stage, epidemiological (age, sex), histological (presence of gastritis, ulcer, H. pylori infection, plasmacytic differentiation, Ki-67 index), and morphological (tumor size, superficial lesions or mass-forming) characteristics.
RESULTS: Thirty-six patients (52 %) had positive PET/CT (average SUVmax was 9±6.7; lesion-to-liver SUVmax ratio 3.7±2.6, lesion-to-blood pool SUVmax ratio 4.8±3.3) at the corresponding gastric lesion; the remaining 33 were not 18F-FDG-avid. In the univariate analysis, 18F-FDG avidity was significantly associated with morphological features (mass forming p<0.001 and high maximum diameter p<0.001), Ann Arbor stage (p=0.010), and Ki67 index (p<0.001) and not correlated with age, sex, presence of gastritis, ulcer, Helicobacter pylori infection, and plasmacytic differentiation. In the multivariate analysis, the correlations with gross morphological appearance, Ann Arbor stage, and Ki-67 score were confirmed. SUVmax, lesion-to-liver SUVmax ratio, and lesion-to-blood pool SUVmax ratio correlated significantly only with Ki67 index (p=0.047; p=0.012; p=0.042).
CONCLUSIONS: 18F-FDG avidity was noted in 52 % of gastric MALT lymphoma and this avidity is correlated with gross morphological characteristics, tumor stage, and Ki-67 index. SUVmax, lesion-to-liver SUVmax ratio, and lesion-to-blood pool SUVmax ratio are correlated only with Ki-67 index, and only lesion-to-liver SUVmax ratio was independently associated with Ki-67 score.

Entities:  

Keywords:  18F-FDG PET/CT; FDG avidity; Gastric MALT lymphoma; Gastric lymphoma; MALT lymphoma

Mesh:

Substances:

Year:  2016        PMID: 27619357     DOI: 10.1007/s00259-016-3518-y

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  40 in total

1.  Gastric marginal zone lymphoma of MALT type: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  E Zucca; C Copie-Bergman; U Ricardi; C Thieblemont; M Raderer; M Ladetto
Journal:  Ann Oncol       Date:  2013-10       Impact factor: 32.976

2.  Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification.

Authors:  Bruce D Cheson; Richard I Fisher; Sally F Barrington; Franco Cavalli; Lawrence H Schwartz; Emanuele Zucca; T Andrew Lister
Journal:  J Clin Oncol       Date:  2014-09-20       Impact factor: 44.544

3.  18F-Fluoro-deoxy-glucose positron emission tomography in lymphoma of mucosa-associated lymphoid tissue: histology makes the difference.

Authors:  M Hoffmann; S Wöhrer; A Becherer; A Chott; B Streubel; K Kletter; M Raderer
Journal:  Ann Oncol       Date:  2006-09-15       Impact factor: 32.976

4.  Comparison between endoscopic macroscopic classification and F-18 FDG PET findings in gastric mucosa-associated lymphoid tissue lymphoma patients.

Authors:  Yasumitsu Hirose; Hayato Kaida; Masatoshi Ishibashi; Jun Uozumi; Shunji Arikawa; Seiji Kurata; Naofumi Hayabuchi; Keita Nakahara; Koichi Ohshima
Journal:  Clin Nucl Med       Date:  2012-02       Impact factor: 7.794

5.  (18)F-FDG avidity in lymphoma readdressed: a study of 766 patients.

Authors:  Michal Weiler-Sagie; Olga Bushelev; Ron Epelbaum; Eldad J Dann; Nissim Haim; Irit Avivi; Ayelet Ben-Barak; Yehudit Ben-Arie; Rachel Bar-Shalom; Ora Israel
Journal:  J Nucl Med       Date:  2009-12-15       Impact factor: 10.057

6.  18F-FDG PET in mucosa-associated lymphoid tissue (MALT) lymphoma.

Authors:  Lapo Alinari; Paolo Castellucci; Rebecca Elstrom; Valentina Ambrosini; Vittorio Stefoni; Cristina Nanni; Arnold Berkowitz; Monica Tani; Mohsen Farsad; Roberto Franchi; Stefano Fanti; Pier Luigi Zinzani
Journal:  Leuk Lymphoma       Date:  2006-10

7.  18F-FDG uptake in primary gastric malignant lymphoma correlates with glucose transporter 1 expression and histologic malignant potential.

Authors:  Yuko Watanabe; Hiroaki Suefuji; Yasumitsu Hirose; Hayato Kaida; Gen Suzuki; Jun Uozumi; Etsuyo Ogo; Mayumi Miura; Konomi Takasu; Kanoko Miyazaki; Keita Nakahara; Masatoshi Ishibashi; Takashi Okamura; Koichi Ohshima; Naofumi Hayabuchi
Journal:  Int J Hematol       Date:  2012-12-02       Impact factor: 2.490

8.  18F-fluorodeoxyglucose positron emission tomography (18F-FDG-PET) for staging and follow-up of marginal zone B-cell lymphoma.

Authors:  Martha Hoffmann; Kurt Kletter; Alexander Becherer; Ulrich Jäger; Andreas Chott; Markus Raderer
Journal:  Oncology       Date:  2003       Impact factor: 2.935

9.  FDG avidity and PET/CT patterns in primary gastric lymphoma.

Authors:  Lea Radan; Doron Fischer; Rachel Bar-Shalom; Eldad J Dann; Ron Epelbaum; Nissim Haim; Diana Gaitini; Ora Israel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-04-17       Impact factor: 9.236

10.  Correlation between Semi-Quantitative (18)F-FDG PET/CT Parameters and Ki-67 Expression in Small Cell Lung Cancer.

Authors:  Soyeon Park; Eunsub Lee; Seunghong Rhee; Jaehyuk Cho; Sunju Choi; Sinae Lee; Jae Seon Eo; Kisoo Pahk; Jae Gol Choe; Sungeun Kim
Journal:  Nucl Med Mol Imaging       Date:  2016-01-05
View more
  14 in total

1.  18F-FDG PET/CT in primary brain lymphoma.

Authors:  Domenico Albano; Giovanni Bosio; Mattia Bertoli; Raffaele Giubbini; Francesco Bertagna
Journal:  J Neurooncol       Date:  2017-11-17       Impact factor: 4.130

2.  Pulmonary mucosa-associated lymphoid tissue lymphoma: 18F-FDG PET/CT and CT findings in 28 patients.

Authors:  Domenico Albano; Andrea Borghesi; Giovanni Bosio; Mattia Bertoli; Roberto Maroldi; Raffaele Giubbini; Francesco Bertagna
Journal:  Br J Radiol       Date:  2017-10-03       Impact factor: 3.039

3.  Uptake of [18F]fluorodeoxyglucose in initial positron-emission tomography predicts survival in MALT lymphoma.

Authors:  Shunan Qi; May Y Huang; Yong Yang; Heiko Schöder; Sewit Teckie; Ariela Noy; Karen Chau; Joachim Yahalom
Journal:  Blood Adv       Date:  2018-03-27

Review 4.  13N-NH3 PET/CT in oncological disease.

Authors:  Domenico Albano; Raffaele Giubbini; Francesco Bertagna
Journal:  Jpn J Radiol       Date:  2019-10-10       Impact factor: 2.374

5.  Different CT imaging findings between histological subtypes in patients with primary thyroid lymphoma.

Authors:  Tomohiro Ando; Hiroki Kato; Masayuki Matsuo
Journal:  Radiol Med       Date:  2022-01-15       Impact factor: 3.469

6.  Intelligent Reconstruction Algorithm-Based Computed Tomography Images for Automatic Detection of Gastric Tumor.

Authors:  Yuanyuan Zhang; Lisha Chen; Huixin Chen
Journal:  Comput Math Methods Med       Date:  2022-06-28       Impact factor: 2.809

7.  A case of primary hepatic extranodal marginal zone B-cell mucosa-associated lymphoid tissue (MALT) lymphoma treated by radiofrequency ablation (RFA), and a literature review.

Authors:  Zhe Xu; Chong Pang; Jidong Sui; Zhenming Gao
Journal:  J Int Med Res       Date:  2021-03       Impact factor: 1.671

8.  Prognostic significance of interim PET/CT response for the treatment of advanced-stage marginal zone lymphoma in the post-rituximab era.

Authors:  Ho-Young Yhim; Deok-Hwan Yang; Ga-Young Song; Sang Eun Yoon; Seok Jin Kim; Jin Seok Kim; Youngil Koh; Joon-Ho Moon; Sung Yong Oh; Ho Sup Lee; Ho-Jin Shin; Young Rok Do; Won Sik Lee; Dae Sik Kim; Yong Park
Journal:  Sci Rep       Date:  2020-07-15       Impact factor: 4.379

9.  Texture Analysis Improves the Value of Pretreatment 18F-FDG PET/CT in Predicting Interim Response of Primary Gastrointestinal Diffuse Large B-Cell Lymphoma.

Authors:  Yiwen Sun; Xiangmei Qiao; Chong Jiang; Song Liu; Zhengyang Zhou
Journal:  Contrast Media Mol Imaging       Date:  2020-08-21       Impact factor: 3.161

10.  Role of F-18 FDG PET/CT in non-conjunctival origin ocular adnexal mucosa-associated lymphoid tissue (MALT) lymphomas.

Authors:  Hye Lim Park; Joo Hyun O; Sonya Youngju Park; Seung-Eun Jung; Gyeongsin Park; Byung-Ock Choi; Sung Hoon Kim; Young-Woo Jeon; Seok-Goo Cho; Suk-Woo Yang
Journal:  EJNMMI Res       Date:  2019-11-21       Impact factor: 3.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.